Rana Pratibha, Alba Aponte Patria, Babar Ghufran
Children's Mercy Hospital, 3101 Broadway Blvd., Kansas City, MO 64111, USA.
Department of Pediatric Endocrinology, Children's Mercy Hospital, 3101 Broadway Blvd., Kansas City, MO 64111, USA.
Case Rep Endocrinol. 2020 Feb 12;2020:1283464. doi: 10.1155/2020/1283464. eCollection 2020.
Lithium therapy has been associated with several endocrine disorders including thyroid dysfunction, diabetes insipidus, and hyperparathyroidism. While its suppressive effect on thyroid function is well known, it is very rare to observe lithium-induced hyperthyroidism especially in the pediatric population. Here, we describe a case of lithium-induced hyperthyroidism in an adolescent female with bipolar disorder. The patient is a 17-year-old female who was treated with lithium for bipolar disorder and presented with symptoms and laboratory findings consistent with hyperthyroidism. Since thyroid autoantibodies were negative, thyroid dysfunction was attributed to lithium toxicity. Indeed, her clinical and biochemical hyperthyroid state resolved after stopping lithium therapy. Lithium-associated hyperthyroidism can occur in the pediatric population. We propose close monitoring of thyroid hormone levels in children on lithium therapy.
锂盐治疗与多种内分泌疾病有关,包括甲状腺功能障碍、尿崩症和甲状旁腺功能亢进。虽然其对甲状腺功能的抑制作用众所周知,但锂诱导的甲状腺功能亢进非常罕见,尤其是在儿科人群中。在此,我们描述一例患有双相情感障碍的青少年女性锂诱导的甲状腺功能亢进病例。该患者为17岁女性,因双相情感障碍接受锂盐治疗,出现了与甲状腺功能亢进相符的症状和实验室检查结果。由于甲状腺自身抗体为阴性,甲状腺功能障碍归因于锂中毒。事实上,停止锂盐治疗后,她的临床和生化甲状腺功能亢进状态得到缓解。锂相关的甲状腺功能亢进可发生在儿科人群中。我们建议对接受锂盐治疗的儿童密切监测甲状腺激素水平。